In blood vessels, serotonin 5-HT2B receptors mainly mediate relaxation, although their activation by the selective agonist BW723C86 is known to exert contraction of aorta in deoxycorticosterone acetate (DOCA)-salt and N(omega)-nitro-L-arginine (L-NAME) hypertensive rats [Russel et al., 2002; Banes et al., 2003 ] and in mice with type 2 diabetes [Nelson et al., 2012] . The unmasking effect on vasoconstriction can be caused by a shift in the balance of tyrosine phosphorylation in smooth muscle cells (SMC) due to oxidative stress induced inhibition of protein tyrosine phosphatases (PTP). We have demonstrated that BW723C86 which does not cause contraction of rat aorta and mesenteric artery rings, evoked a vasoconstrictor Manuscript Click here to download Manuscript: Mironova et al Manuscript.doc 2 effect in the presence of PTP inhibitors sodium orthovanadate (Na3VO4) or BVT948.
Introduction
Serotonin (5-hydroxytriptamine, 5-HT) plays an important role in regulating embryonic development, the functions of intestine, nervous, cardiovascular and other systems in adult organism. The action of serotonin is mediated by seven types of 5-HT receptors. In blood vessels, 5-HT1B-, 5-HT1D-, 5-HT1F-, 5-HT2A-, 5-HT2B-, 5-HT4-and 5-HT7-receptors have been identified [1, 2] . 5-HT2A receptors play the main role in implementation of the vasoconstrictor effect of serotonin [3] . For several vessels contraction was demonstrated in response to 5-HT1B receptors stimulation [3] . 5-HT2B receptors are expressed in endothelial cells and vascular SMC [1, 2, 4] .
Available data suggest that the 5-HT2B receptors mediate vasodilation through activation of NO synthesis [4] . On the other hand, an agonist of 5-HT2B receptors BW723C86 [5] causes constriction of de-endothelized renal arteries [6] , suggesting a direct effect on the SMC. Normally BW723C86 has no effect on basal tone of the aorta and mesenteric arteries, however it induces vasoconstriction in DOCA-salt hypertensive rats [7] and L-NAME hypertensive rat [8] as well as in mice with type 2 diabetes [9] . This suggests that 5-HT2B receptors operate as both vasodilators and vasoconstrictors, but normally their contractile effect is not manifested. The purpose of the present study was to find the conditions that lead to unmasking of vasoconstrictor effect of BW723C86. Since it is known that c-Src kinase plays an important role in the contractile action of serotonin [10] , and protein tyrosine phosphatases (PTP) are inhibited by reactive oxygen species (ROS) which are increasingly produced in hypertension and diabetes [11] , we assumed that an equilibrium shift in the tyrosine phosphatases/tyrosine kinases activities towards tyrosine phosphorylation should cause unmasking of blood vessels contraction in response to BW723C86. To test this hypothesis, we used sodium orthovanadate (Na3VO4) and BVT948, which can induce an elevation of the intracellular concentration of ROS and promote inhibition of PTP through oxidation of SH-groups of cysteine [12, 13] , i.e. mimic processes that occur in oxidative stress. Calcium is playing a major role in vasoconstriction, so we studied whether inhibition of PTP potentiates elevation of [Ca 2+ ]i in rat aorta SMC in response to activation of 5-HT2B receptors.
2.
Materials and methods
Reagents.
BW723C86 , RS127445, PP2, PP3, genistein from Tocris; DCFH-DA, Fura-2/AM from Molecular Probes; serotonin, angiotensin II, N-Acetyl-L-cysteine, TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl), VAS2870, Na3VO4, BVT948 from Sigma-Aldrich.
Animals
Male Wistar rats weighting 250-300 g were anesthetized with 25% urethane (4 ml/kg) and decapitated. The thoracic part of aorta and superior mesenteric artery were then removed. All manipulations with the animals were performed in accordance with the National
Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No.
8023, revised 1978).

Cell culture
Vascular SMC were derived from aorta of male Wistar rats in an explant method previously described in [14] and cultured in Dulbecco's Modified Eagle Medium (SigmaAldrich) containing 10% fetal calf serum.
Measurement of the mRNA expression of 5-HT2B, 5-HT2AR, 5-HT2C and 5-HT1B receptors
Total RNAs from rat aorta, mesenteric artery and rat aorta SMC was isolated using RNeasy MiniKit (QIAGEN). Reversed transcription was carried out using oligodT-primer. 
Registration of aorta and mesenteric artery contraction
Blood vessels, isolated from Wistar rats, were cleaned from connective tissue and cut into rings with a width of 2-3 mm. The rings were mounted on the holders in chambers filled with Krebs-Henseleit solution (37 o C) perfused with 95% О2 / 5% СО2
and extended with a force of 1 g for aorta and 0.75 g for mesentheric artery.
Experiments were performed on a wire myograph (ADInstruments, Australia) using LabChart program for data acquisition and analysis. 
Detection of ROS in the smooth-muscle cells
ROS generation in rat aorta SMC was assessed using 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) as a probe. The cells grown in 96-well plates were incubated with 2 μM of DCFH-DA during one hour incubation at room temperature. Formation of ROS in the cells was determined by measuring the rate of DCFH oxidation into 2',7'-dichlorofluorescein (DCF). DCF fluorescence was measured at excitation wavelength of 485 ± 20 nm and with emitter bandpass of 527 ± 15 nm. The rate of fluorescence rise was taken as an index ROS generation.
2.8.Statistics
Data are presented as mean±SEM of 6 to 18 measurements. Statistical significance was calculated using MedCalc statistical software according the one-way analysis of variance and Student-Neuman-Keuls test. Differences were considered to be significant at p<0.05.
Results
Assessment of 5-HT2 receptors mRNA in rat aorta and mesenteric arteries and in SMC
isolated from rat aorta mRNA of elongation factor EF1a was used as endogenous control and the contents of 5-HT2A, 5-HT2B, 5-HT2C and 5-HT1B receptor mRNA in aorta and superior mesenteric artery of rat and in cultured SMC were calculated based on CT values.
In both vessels and in SMC, the mRNA of 5-HT2A receptor is dominating (Fig.1 ).
The content of 5-HT2B receptor mRNA relative to mRNA coding 5-HT2A receptor in aorta, mesenteric arteries and SMC was determined as 6.1±1.4, 5.4±0.6 and 36±11.1%, respectively. The relative level of 5-HT2C receptor mRNA in aorta and mesenteric artery was 0.22±0.14% and 0.24±0.03%, respectively, and only trace levels in SMC, 0.012±0.002%. The relative content of 5-HT1B mRNA was 41.3±4.6% and 55.1±4.6% in the aorta and mesenteric artery and 0.74±0.19% in SMC. Thus, 5HT2B receptors are expressed in the rat aorta and mesenteric arteries, and in SMC isolated from rat aorta; the level of their expression in the SMC is comparable with that of 5-HT2A receptors.
Effects of BW723C86 on the contractility of rat aorta and mesenteric arteries in the presence of PTP inhibitors Na3VO4 or BVT948
To investigate whether inhibition of PTP will unmask the vasoconstrictor effect of BW723C86 on isolated blood vessels, experiments were carried out on the rings of rat mesenteric arteries and aorta. There was no vasoconstrictive effect of BW723C86 at concentration range 0.1-100 M. However, added after PTP inhibitors Na3VO4 (500 M) or BVT948 (0.1 M), BW723C86 (1 M) induces contraction of mesentheric artery rings ( Fig. 2A) . Na3VO4 or BVT948 themselves at concentrations 500 and 0.1M respectively did not cause contraction. At higher concentrations, 1 mM for Na3VO4 and 1 M for BVT948, each of them induces contraction of mesentheric artery ring without BW723C86.
Effect of Na3VO4 on aorta at 500 µM was not consistent, causing either contraction or did not influence the aortic tone. Administration of 1 mM Na3VO4 to rat aortic rings resulted in their contraction, the force of which reached a maximum within 10 min. The initial contraction induced by 1 mM Na3VO4 was followed by slow relaxation. BW723C86 at 3 µM concentration added to the rings stabilized contraction and constant force was maintained at least for 25 min (Fig. 2B,C) .
Effects of orthovanadate and PTK inhibitors on [Ca 2+ ]i elevation induced by BW723C86 and 5-HT in SMC isolated from rat aorta
A rise of [Ca 2+ ]i in vascular SMC is a trigger for vessel contraction. Therefore we studied whether inhibition of PTP activity will potentiate calcium signaling via 5-HT2B receptors in SMC. Na3VO4 was chosen to evaluate how inhibition of PTP will affect signal transduction from 5-HT2B receptors. Another PTP inhibitor BVT948 was not used in these experiments because its fluorescence overlaps with Fura2 fluorescence. Na3VO4 increased elevation of [Ca 2+ ]i in response to BW723C86 by more than 5 times (Fig. 3A) . The potentiating effect of Na3VO4 on the calcium signal was manifested equally over a concentration range of 100 to 500 µM. Antagonist of 5-HT2B receptors RS127445 suppressed [Ca 2+ ]i elevation in response to BW723C86 (Fig. 3B) . Serotonin is a more powerful inducer of [Ca 2+ ]i elevation in rat aorta SMC compared to BW723C86 (Fig. 3A) . Na3VO4 increased the serotonin-induced elevation ]i increase induced by BW723S86 added after Na3VO4 (Fig. 3B) .
Inactive analogue PP3 did not affect the calcium response. PP2 was also shown to inhibit the [Ca 2+ ]i elevation due to 5-HT (Fig. 3C) . Thus, Src kinase or other PTK belonging to the Src kinases family is involved in calcium signaling of 5-HT2B receptors.
ROS formation under the influence of orthovanadate and BW723C86 in SMC
The above data suggest that Na3VO4 augments the calcium response upon activation of 5-HT2B receptors through inhibition of PTP. It was previously shown that suppression of PTP activity is the result of oxidation of SH-groups [13] . It is known that orthovanadate can induce formation of H2O2 via superoxide anion as an intermediate product [16] and H2O2 inside the cell is able to oxidize SH-group in active center of PTP [17, 18] . We therefore studied the effects of Na3VO4 and BW723S86 on accumulation of ROS in the SMC using a cell-permeable probe DCFH-DA, which is cleaved in the cells to DCFH. DCFH can be oxidized by H2O2 and to a lesser degree by superoxide anion forming the fluorescent compound 2',7'-dichlorofluorescein (DCF) [19] . The rate of fluorescence rise was taken as an index ROS generation. Without any additives there was a slow elevation in fluorescence, representing spontaneous ROS formation (Fig. 4A) . Administration of 300 µM Na3VO4 made the curve steeper that indicates increased formation of intracellular ROS. Furthermore, addition of BW723C86 (10 µM) caused a sharp increase in the reaction rate (Fig. 4B) , thus indicating activation of ROS. Without orthovanadate BW723C86 did not affect the rate of oxidation of DCFH in SMC.
3.5.Suppression of BW723C86-induced [Ca
2+ ]i elevation by N-acetylcysteine and inhibitor of NADPH-oxidases VAS2870
Since Na3VO4 effects are associated with the ROS formation, which can act as (Fig. 4C) . Tempol had no effect on the BW723C86-induced calcium signaling. Since tempol catalytically removes superoxide anions though has no antioxidant activity against hydrogen peroxide [20] . we can eliminate the superoxide anion as a kind of ROS directly involved in the implementation of the potentiating effect of Na3VO4. To investigate the role of NADPH-oxidases in realization of the effect of BW723C86 on calcium signaling in SMC we used their selective inhibitor VAS2870 [21, 22] . VAS2870 at a concentration of 10 M inhibited by 79+4% the increase in [Ca 2+ ]i that was induced by BW723C86 added after 200 M Na3VO4 (Fig. 4C) .
Discussion
In this work we have demonstrated that silent vasoconstrictive 5-HT2B receptors are present in rat aorta and mesentheric artery and their functional activity is unmasked under the action of PTP inhibitors Na3VO4 and BVT948. Our data suggest that this occurs due to potentiating of calcium signaling via these receptors. receptors. According to our knowledge, these is the first demostration of 5-HT2B
Elevation of [Ca
receptors involvement in calcium signaling in vascular SMC.
Earlier it was shown that orthovanadate increases the level of phosphorylation of proteins on tyrosine residues in SMC by inhibiting PTP [23, 24] . We assume that potentiation of calcium signaling via 5-HT2B receptors and unmasking of aorta and previously shown with a specific probe HyPer [27] . Our data suggest that 5-HT2B
receptors are involved in the implementation of this effect.
The cause of vasoconstrictor action of 5-HT2B receptors at some diseases may be an elevation of their expression in vascular SMC [28] , as well as increase in signal transmission efficiency from these receptors. Our data apparently gives a clue to the understanding of the mechanism of the vasoconstrictive action of 5-HT2B receptors in L-NAME induced hypertension and DOCA-salt hypertensive rats [8, 29] and in mouse model of type II diabetes mellitus [9] . Increased intracellular concentration of ROS is a well established pathogenic factor of hypertension and diabetes [11] . We suggest that manifestation of vasoconstrictive action of 5-HT2B receptors in these pathological states occurs due to oxidative stress evoked inhibition of PTP and potentiation of Ca-signaling in vascular SMC via 5-HT2B receptors.
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